Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
retinal neovascularization
MeSH D015861 - retinal neovascularization
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012164:
Retinal diseases
2 Companies
1 Drug
$
Success rate
D009389:
Pathologic neovascularization
0 Companies
0 Drugs
Success rate
D015861:
Retinal neovascularization
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50
%
1/2
Phase 2
60
%
6/10
Phase 3
40
%
2/5
Approved:
0
Overall Success rate:
12%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use